236 related articles for article (PubMed ID: 27704617)
21. The gastric mucosa 25 years after proximal gastric vagotomy.
Sagatun L; Jianu CS; Fossmark R; Mårvik R; Nordrum IS; Waldum HL
Scand J Gastroenterol; 2014 Oct; 49(10):1173-80. PubMed ID: 25157752
[TBL] [Abstract][Full Text] [Related]
22. The gastrin receptor antagonist netazepide (YF476) prevents oxyntic mucosal inflammation induced by Helicobacter pylori infection in Mongolian gerbils.
Sørdal Ø; Waldum H; Nordrum IS; Boyce M; Bergh K; Munkvold B; Qvigstad G
Helicobacter; 2013 Dec; 18(6):397-405. PubMed ID: 23865485
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of three novel cholecystokinin-B/gastrin receptor antagonists: a study of their effects on rat stomach enterochromaffin-like cell activity.
Ding XQ; Lindström E; Håkanson R
Pharmacol Toxicol; 1997 Nov; 81(5):232-7. PubMed ID: 9396089
[TBL] [Abstract][Full Text] [Related]
24. Plasma ghrelin concentrations in type 1 diabetic patients with autoimmune atrophic gastritis.
Alonso N; Granada ML; Salinas I; Reverter JL; Flores L; Ojanguren I; Martínez-Cáceres EM; Sanmartí A
Eur J Endocrinol; 2007 Dec; 157(6):763-9. PubMed ID: 18057384
[TBL] [Abstract][Full Text] [Related]
25. Gene expression of ornithine decarboxylase, cyclooxygenase-2, and gastrin in atrophic gastric mucosa infected with Helicobacter pylori before and after eradication therapy.
Konturek PC; Rembiasz K; Konturek SJ; Stachura J; Bielanski W; Galuschka K; Karcz D; Hahn EG
Dig Dis Sci; 2003 Jan; 48(1):36-46. PubMed ID: 12645788
[TBL] [Abstract][Full Text] [Related]
26. [Chronic autoimmune gastritis : a multidisciplinary management].
Valdes-Socin H; Leclercq P; Polus M; Rohmer V; Beckers A; Louis E
Rev Med Liege; 2019 Nov; 74(11):598-605. PubMed ID: 31729849
[TBL] [Abstract][Full Text] [Related]
27. Chromogranin A as a useful neuroendocrine marker in patients with autoimmune Addison's disease.
El Ali Z; Fichna M; Piniewska J; Kosowicz J; Grzymisławski M
J Endocrinol Invest; 2010 Mar; 33(3):186-91. PubMed ID: 19794299
[TBL] [Abstract][Full Text] [Related]
28. Cholecystokinin-B/gastrin receptor blockade suppresses the activity of rat stomach ECL cells.
Ding XQ; Lindström E; Håkanson R
Pharmacol Toxicol; 1997 Jul; 81(1):19-25. PubMed ID: 9258980
[TBL] [Abstract][Full Text] [Related]
29. Single oral doses of netazepide (YF476), a gastrin receptor antagonist, cause dose-dependent, sustained increases in gastric pH compared with placebo and ranitidine in healthy subjects.
Boyce M; David O; Darwin K; Mitchell T; Johnston A; Warrington S
Aliment Pharmacol Ther; 2012 Jul; 36(2):181-9. PubMed ID: 22607579
[TBL] [Abstract][Full Text] [Related]
30. Serum chromogranin A as a screening test for gastric enterochromaffin-like cell hyperplasia during acid-suppressive therapy.
Sanduleanu S; De Bruïne A; Stridsberg M; Jonkers D; Biemond I; Hameeteman W; Lundqvist G; Stockbrügger RW
Eur J Clin Invest; 2001 Sep; 31(9):802-11. PubMed ID: 11589723
[TBL] [Abstract][Full Text] [Related]
31. Gastric Neuroendocrine Tumor and Duodenal Gastrinoma With Chronic Autoimmune Atrophic Gastritis.
Chen WC; Warner RRP; Harpaz N; Zhu H; Roayaie S; Kim MK
Pancreas; 2019 Jan; 48(1):131-134. PubMed ID: 30531243
[TBL] [Abstract][Full Text] [Related]
32. Risk factors of type 1 gastric neuroendocrine neoplasia in patients with chronic atrophic gastritis. A retrospective, multicentre study.
Campana D; Ravizza D; Ferolla P; Faggiano A; Grimaldi F; Albertelli M; Ricci C; Santini D; Brighi N; Fazio N; Colao A; Ferone D; Tomassetti P
Endocrine; 2017 Jun; 56(3):633-638. PubMed ID: 27592118
[TBL] [Abstract][Full Text] [Related]
33. Are patients with autoimmune thyroid disease and autoimmune gastritis at risk of gastric neuroendocrine neoplasms type 1?
Alexandraki KI; Nikolaou A; Thomas D; Syriou V; Korkolopoulou P; Sougioultzis S; Kaltsas G
Clin Endocrinol (Oxf); 2014 May; 80(5):685-90. PubMed ID: 24118101
[TBL] [Abstract][Full Text] [Related]
34. Chromogranin A: is it a useful marker of neuroendocrine tumors?
Campana D; Nori F; Piscitelli L; Morselli-Labate AM; Pezzilli R; Corinaldesi R; Tomassetti P
J Clin Oncol; 2007 May; 25(15):1967-73. PubMed ID: 17513802
[TBL] [Abstract][Full Text] [Related]
35. Multifocal gastric carcinoid tumours, achlorhydria, and hypergastrinaemia.
Harvey RF; Bradshaw MJ; Davidson CM; Wilkinson SP; Davies PS
Lancet; 1985 Apr; 1(8435):951-4. PubMed ID: 2859413
[TBL] [Abstract][Full Text] [Related]
36. Serum chromogranin A level continuously rises with the progression of type 1 diabetes, and indicates the presence of both enterochromaffin-like cell hyperplasia and autoimmune gastritis.
Herold Z; Herold M; Nagy P; Patocs A; Doleschall M; Somogyi A
J Diabetes Investig; 2020 Jul; 11(4):865-873. PubMed ID: 31883432
[TBL] [Abstract][Full Text] [Related]
37. Chromogranin Serves as Novel Biomarker of Endocrine and Gastric Autoimmunity.
Ebert A; König J; Frommer L; Schuppan D; Kahaly GJ
J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32436949
[TBL] [Abstract][Full Text] [Related]
38. Serum gastrin in chronic gastritis.
Korman MG; Strickland RG; Hansky J
Br Med J; 1971 Apr; 2(5752):16-8. PubMed ID: 5550864
[TBL] [Abstract][Full Text] [Related]
39. Polyautoimmunity in autoimmune gastritis.
Kalkan Ç; Soykan I
Eur J Intern Med; 2016 Jun; 31():79-83. PubMed ID: 27085391
[TBL] [Abstract][Full Text] [Related]
40. Neuroendocrine tumor markers and enterochromaffin-like cell hyper/dysplasia in type 1 diabetes.
De Block CE; Colpin G; Thielemans K; Coopmans W; Bogers JJ; Pelckmans PA; Van Marck EA; Van Hoof V; Martin M; De Leeuw IH; Bouillon R; Van Gaal LF
Diabetes Care; 2004 Jun; 27(6):1387-93. PubMed ID: 15161793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
